abstract |
The present invention relates to at least one novel anti-RELP fusion antibody, including isolated nucleic acids that encode at least one anti-RELP fusion antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices. |